Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.
Paying user area
Try for free
Amgen Inc. pages available for free this week:
- Statement of Comprehensive Income
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Solvency Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Price to FCFE (P/FCFE)
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Selected Financial Data since 2005
- Current Ratio since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Amgen Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Amgen Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
US$ in millions
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
The liabilities and stockholders’ equity of the company exhibit notable fluctuations over the observed period from March 2021 to December 2025. Overall, total liabilities generally increased, with a significant jump in late 2022 and early 2023, before stabilizing and decreasing slightly towards the end of the period. Stockholders’ equity experienced a more volatile trajectory, initially declining before a substantial recovery and subsequent moderate fluctuations.
- Current Liabilities
- Current liabilities demonstrated an initial increase from $12.869 billion in March 2021 to a peak of $15.687 billion in December 2022. This was followed by a decrease to $15.687 billion in December 2022, then a rise to $25.489 billion in December 2025. A significant driver of this trend appears to be the accounts payable, which increased substantially from $1.396 billion in March 2021 to $3.010 billion in June 2025, before decreasing to $2.367 billion in December 2025. Accrued liabilities also consistently increased over the period, rising from $9.917 billion to $18.523 billion. The current portion of long-term debt showed considerable volatility, peaking at $4.324 billion in June 2021, then decreasing significantly before rising again to $4.599 billion in December 2025.
- Noncurrent Liabilities
- Noncurrent liabilities generally increased from $40.336 billion in March 2021 to $45.773 billion in December 2022, then experienced a substantial increase to $83.372 billion in March 2023. This was largely driven by a significant increase in long-term debt, excluding the current portion, which rose from $31.129 billion in March 2021 to $60.761 billion in March 2023. Subsequently, noncurrent liabilities decreased to $56.439 billion in December 2025, with long-term debt decreasing to $50.005 billion. Long-term tax liabilities decreased steadily over the period, from $7.037 billion to $2.690 billion. Long-term deferred tax liabilities were first reported in September 2022 and decreased from $2.354 billion to $1.366 billion in December 2025. Other noncurrent liabilities remained relatively stable, fluctuating between $2.170 billion and $2.949 billion.
- Stockholders’ Equity
- Stockholders’ equity experienced a decline from $9.334 billion in March 2021 to a low of $6.700 billion in June 2022. A substantial recovery followed, with equity increasing to $9.619 billion in September 2025. This recovery was primarily driven by an increase in common stock and additional paid-in capital, which remained relatively stable around $32-34 billion, and a reduction in accumulated deficit, which decreased from -$24.600 billion in June 2022 to -$25.107 billion in December 2025. Accumulated other comprehensive loss also decreased over the period, from -$833 million to -$258 million.
In summary, the company’s balance sheet reflects a trend of increasing liabilities, particularly in the short term, alongside a recovery in stockholders’ equity. The significant increase in long-term debt in early 2023 warrants further investigation, as does the substantial rise in accounts payable and accrued liabilities. The reduction in accumulated deficit contributed positively to the improvement in stockholders’ equity.